Rapport Therapeutics, Inc., headquartered in Boston, presented follow-up data at a conference related to neurology.
Steady: 1 in the last 7 days
Updated tuesday
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Rapport Therapeutics, Inc., headquartered in Boston, presented follow-up data at a conference related to neurology.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- RAP-219, a drug developed by Rapport Therapeutics, showed efficacy in treating bipolar mania.Sub-event
Rapport Therapeutics presented follow-up data at a conference while based in Boston.1 source
Company secures licensing agreement for global commercial opportunities following data presentation.1 source
Keep exploring
The entities involved
-
Boston
capital and largest city of Massachusetts, United States